Evolent Health, Inc. (9EH.F)
| Previous close | 27.20 |
| Open | 26.40 |
| Bid | 25.80 x 26000 |
| Ask | 26.00 x 26000 |
| Day's range | 26.40 - 26.40 |
| 52-week range | 22.40 - 33.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 3.007B |
| Beta (5Y monthly) | 1.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.19 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 28.33 |
PR NewswireEvolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after market close, with a conference call to follow at 5 p.m. ET.
Simply Wall St.Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years
Evolent Health, Inc. ( NYSE:EVH ) shareholders might be concerned after seeing the share price drop 12% in the last...
ZacksDoes Evolent Health (EVH) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 34.5% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
